54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
12:33 UTC
|
NET
Cloudflare
|
◎ Target | Gray Powell ★★★★★ #27 | Buy | $314.00→ $382.00+21.7% |
|
Aug 07
12:33 UTC
|
MIAX
Miami International
|
◎ Target | Chris Allen not yet tracked | Market Perform | $46.00→ $48.00+4.3% |
|
Aug 07
12:33 UTC
|
MARA
Marathon Digital
|
◎ Target | Brett Knoblauch ★☆☆☆☆ #3220 | Overweight | $14.00→ $12.00-14.3% |
|
Aug 07
12:33 UTC
|
LYFT
Lyft
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Neutral | $14.00→ $17.00+21.4% |
|
Aug 07
12:33 UTC
|
LNG
Cheniere Energy
|
◎ Target | Theresa Chen ★★★☆☆ #1737 | Overweight | $274.00→ $279.00+1.8% |
|
Aug 07
12:33 UTC
|
LFST
LifeStance Health Group
|
◎ Target | David Larsen ★★★★☆ #561 | Buy | $15.00→ $16.00+6.7% |
|
Aug 07
12:33 UTC
|
KRMN
Karman
|
◎ Target | Austin Bohlig ★☆☆☆☆ #3149 | Buy | $125.00→ $80.00-36.0% |
|
Aug 07
12:33 UTC
|
IFRX
InflaRx
|
◎ Target | Steve Seedhouse not yet tracked | Overweight | $4.00→ $6.00+50.0% |
|
Aug 07
12:33 UTC
|
ICUI
ICU Medical
|
◎ Target | Sam Eiber ★★★☆☆ #1826 | Buy | $170.00→ $200.00+17.6% |
|
Aug 07
12:33 UTC
|
ICUI
ICU Medical
|
◎ Target | Mike Matson not yet tracked | Buy | $165.00→ $187.00+13.3% |
|
Aug 07
12:33 UTC
|
HALO
Halozyme Therapeutics
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $95.00→ $115.00+21.1% |
|
Aug 07
12:33 UTC
|
GHRS
GH Research
|
◎ Target | Charles Duncan ★★★☆☆ #1914 | Overweight | $35.00→ $40.00+14.3% |
|
Aug 07
12:33 UTC
|
G
Genpact
|
◎ Target | Mayank Tandon ★★★★☆ #398 | Buy | $50.00→ $45.00-10.0% |
|
Aug 07
12:33 UTC
|
FROG
JFrog
|
◎ Target | Mike Cikos ★★★★★ #98 | Buy | $80.00→ $115.00+43.8% |
|
Aug 07
12:33 UTC
|
FROG
JFrog
|
◎ Target | Nick Altmann ★★★★★ #320 | Buy | $100.00→ $115.00+15.0% |
|
Aug 07
12:33 UTC
|
FNF
Fidelity National Financial
|
◎ Target | Terry Ma ★★★★☆ #856 | Equal Weight | $51.00→ $54.00+5.9% |
|
Aug 07
12:33 UTC
|
FIVN
Five9
|
◎ Target | Catharine Trebnick ★★★★☆ #950 | Buy | $29.00→ $32.00+10.3% |
|
Aug 07
12:33 UTC
|
FISV
Fiserv
|
◎ Target | Sanjay Sakhrani ★★★☆☆ #1368 | Outperform | $70.00→ $65.00-7.1% |
|
Aug 07
12:33 UTC
|
FIGS
FIGS
|
◎ Target | Robert Drbul ★★★★☆ #770 | Buy | $20.00→ $22.00+10.0% |
|
Aug 07
12:33 UTC
|
FIGS
FIGS
|
◎ Target | Adrienne Yih ★★★☆☆ #1564 | Overweight | $17.00→ $20.00+17.6% |
|
Aug 07
12:33 UTC
|
FA
First Advantage
|
◎ Target | Manav Patnaik ★★★★☆ #680 | Overweight | $20.00→ $30.00+50.0% |
|
Aug 07
12:33 UTC
|
ETSY
Etsy
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Neutral | $80.00→ $85.00+6.2% |
|
Aug 07
12:33 UTC
|
ETSY
Etsy
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $85.00→ $100.00+17.6% |
|
Aug 07
12:33 UTC
|
ETSY
Etsy
|
◎ Target | Trevor Young ★★★☆☆ #1049 | Overweight | $82.00→ $94.00+14.6% |
|
Aug 07
12:33 UTC
|
EPC
Edgewell Personal Care
|
◎ Target | Lauren Lieberman ★★★☆☆ #1020 | Equal Weight | $28.00→ $29.00+3.6% |
|
Aug 07
12:33 UTC
|
ED
Consolidated Edison
|
◎ Target | Nicholas Campanella ★★★☆☆ #1658 | Underweight | $112.00→ $106.00-5.4% |
|
Aug 07
12:33 UTC
|
CYRX
CryoPort
|
◎ Target | David Saxon ★★★★★ #312 | Buy | $15.00→ $19.00+26.7% |
|
Aug 07
12:33 UTC
|
CQP
Cheniere Energy Partners
|
◎ Target | Theresa Chen ★★★☆☆ #1737 | Underweight | $63.00→ $66.00+4.8% |
|
Aug 07
12:33 UTC
|
CMPS
Compass Pathways
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $70.00→ $65.00-7.1% |
|
Aug 07
12:33 UTC
|
CMC
Commercial Metals
|
◎ Target | Richard Garchitorena ★★★☆☆ #2192 | Equal Weight | $75.00→ $80.00+6.7% |
|
Aug 07
12:33 UTC
|
CLS
Celestica
|
◎ Target | Tim Long ★★★☆☆ #1976 | Overweight | $430.00→ $406.00-5.6% |
|
Aug 07
12:33 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1072 | Overweight | $48.00→ $53.00+10.4% |
|
Aug 07
12:33 UTC
|
CHYM
Chime Financial
|
◎ Target | Nik Cremo ★★★☆☆ #1517 | Overweight | $26.00→ $33.00+26.9% |
|
Aug 07
12:33 UTC
|
CART
Maplebear
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Overweight | $56.00→ $63.00+12.5% |
|
Aug 07
12:33 UTC
|
CARG
CarGurus
|
◎ Target | Marvin Fong ★★☆☆☆ #2592 | Buy | $40.00→ $41.00+2.5% |
|
Aug 07
12:33 UTC
|
BMRN
BioMarin Pharmaceutical
|
◎ Target | Mitchell S. Kapoor not yet tracked | Neutral | $50.00→ $60.00+20.0% |
|
Aug 07
12:33 UTC
|
BLNK
Blink Charging
|
◎ Target | Sameer Joshi ★★☆☆☆ #2898 | Buy | $2.50 |
|
Aug 07
12:33 UTC
|
BATRK
Atlanta Braves
|
◎ Target | Barton Crockett ★★★★☆ #650 | Buy | $75.00→ $73.00-2.7% |
|
Aug 07
12:33 UTC
|
AVTX
Avalo Therapeutics
|
◎ Target | Mitchell S. Kapoor not yet tracked | Buy | $35.00→ $30.00-14.3% |
|
Aug 07
12:33 UTC
|
ATI
ATI
|
◎ Target | Andre Madrid ★★☆☆☆ #2845 | Buy | $180.00→ $270.00+50.0% |
|
Aug 07
12:33 UTC
|
ASTH
Astrana Health
|
◎ Target | Andrew Mok not yet tracked | Overweight | $50.00→ $53.00+6.0% |
|
Aug 07
12:33 UTC
|
AIZ
Assurant
|
◎ Target | Tommy McJoynt not yet tracked | Outperform | $310.00→ $325.00+4.8% |
|
Aug 07
12:33 UTC
|
AIG
American International Group
|
◎ Target | Alex Scott ★★★★☆ #468 | Equal Weight | $80.00→ $81.00+1.2% |
|
Aug 07
12:33 UTC
|
ABNB
Airbnb
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Neutral | $140.00→ $160.00+14.3% |
|
Aug 07
12:33 UTC
|
AAOI
Applied Optoelectronics
|
◎ Target | Ryan Koontz ★☆☆☆☆ #3105 | Buy | $220.00→ $190.00-13.6% |
|
Aug 07
12:33 UTC
|
XPOF
Xponential Fitness
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Aug 07
12:33 UTC
|
VTEX
VTEX
|
↓ Downgrade | firm only | Neutral | $4.50 |
|
Aug 07
12:33 UTC
|
TTD
Trade Desk
|
↓ Downgrade | firm only | Positive→ Neutral | |
|
Aug 07
12:33 UTC
|
TTD
Trade Desk
|
↓ Downgrade | Andrew Marok ★☆☆☆☆ #3036 | Market Perform→ Underperform | |
|
Aug 07
12:33 UTC
|
ROKU
Roku
|
↓ Downgrade | Michael Morris ★★★☆☆ #2031 | Buy→ Neutral |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.